The panel recommended serum levels of phosphate, calcium, and PTH to be monitored starting at CKD stage G3a at intervals of every 6 months, 3–6 months at CKD stage G3b, and at least every 3 months at CKD stage ≥G4 (Table 1). The gene discussed is PTH; the disease is chronic kidney disease.